Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer.
Mehdi GhahartarsFatemeh SedaghatElham KhajaviAmir Ali NejatMahyar MalekzadehAbbas GhaderiMohammad Javad FattahiPublished in: Dermatology research and practice (2021)
According to our results, it can be concluded that IL-17A may play a role in inducing the growth and progression of NMSC and it can be used as a therapeutic target in these patients in future.